Benzinga's Top #PreMarket Losers

shares declined 9.36 percent to $9.78 in pre-market trading. Kandi Technologies reported Q3 earnings of $0.13 per share on revenue of $50.5 million.

shares fell 6.25 percent to $7.50 in pre-market trading. Novavax reported a Q3 loss of $0.12 per share. The company also announced that it has initiated a Phase 3 clinical trial for its RSV F vaccine.

shares dipped 5.17 percent to $1,375.00 in pre-market trading. Priceline reported better-than-expected earnings for the third quarter, but the company issued a weak earnings forecast for the current quarter.

shares tumbled 3.23 percent to $71.60 in pre-market trading after rising 1.38 percent on Friday

fell 3.11 percent to $18.36 in pre-market trading after declining 0.32 percent on Friday.